Skip to content

Faculty profile

Sylvie Marleau

Back to faculty
ResearcherUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Latest papers

  • Ex vivo Ikkβ ablation rescues the immunopotency of mesenchymal stromal cells from diabetics with advanced atherosclerosis.

    Cardiovascular research · 2021

  • Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice.

    Atherosclerosis · 2020 · senior author

  • Immunometabolic modulation of retinal inflammation by CD36 ligand.

    Scientific reports · 2019

All 6 publications

Latest funding

  • Cardioprotective effect of a cyclic azapeptide ligand of CD36 against ischemia-reperfusion damage and dysfunction in mice

    CIHR · 2021 · Nominated PI

    $726,750
  • Azapeptides: A new class of CD36 ligands for the treatment of ischemic heart disease

    CIHR · 2009 · Principal investigator

    $731,018
All 2 grants and awards
Something wrong or missing on this profile? Suggest a correction